Immix Biopharma, Inc.
IMMX
$2.03
-$0.09-4.25%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.58% | -14.78% | -40.11% | -54.85% | -67.00% |
| Total Depreciation and Amortization | 291.27% | 421.45% | 1,998.18% | 2,473.33% | 2,295.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.98% | -0.78% | 22.51% | 95.85% | 167.25% |
| Change in Net Operating Assets | 682.90% | 153.51% | 140.04% | 2,746.27% | 226.35% |
| Cash from Operations | 15.76% | 4.98% | -28.35% | -25.39% | -35.30% |
| Capital Expenditure | -115.92% | -166.53% | -2,160.46% | -1,657.58% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -115.92% | -166.53% | -2,160.46% | -1,657.58% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.84% | -100.00% | 2.74% | 10.70% | 454.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -112.58% |
| Cash from Financing | -95.83% | -100.00% | 3.14% | 8.07% | 408.16% |
| Foreign Exchange rate Adjustments | 88.89% | -105.17% | -110.91% | 3,420.00% | 280.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -208.97% | -175.03% | -95.77% | -95.95% | 296.94% |